Evan Seigerman, BMO Capital Markets, joins ‘Fast Money’ to talk new headwinds facing the pharma sector.
Source link
Trending
- Hedge funds eye betting against Swiss Franc over carry trade rebound
- Chart Master: Short-term opportunity in Apple
- Jim Cramer says Microsoft, Meta and Nvidia pulled ahead of the Mag 7
- Jeff Bezos sells $737 million worth of Amazon shares
- Final Trade: AAPL, ANF, FCX, TGT
- Stock market today: Live updates
- House Republicans take up Trump’s megabill after Senate
- People continue to spend on travel despite economic concerns
Pharma sector still investible, faces added headwinds, says BMO's Seigerman
